Skip NavigationSkip to Content

Helminth Mediated Attenuation of Systemic Inflammation and Microbial Translocation in Helminth-Diabetes Comorbidity

  1. Author:
    Rajamanickam, Anuradha
    Munisankar, Saravanan
    Menon, Pradeep A.
    Dolla, Chandrakumar
    Nutman, Thomas B.
    Babu, Subash
  2. Author Address

    Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Chennai, Tamil Nadu, India.Natl Inst Res TB, Dept Epidemiol, Chennai, Tamil Nadu, India.NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.NCI, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.
    1. Year: 2020
    2. Date: AUG 31
    3. Epub Date: 2020 08 31
  1. Journal: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
  2. FRONTIERS MEDIA SA,
    1. 10
    2. Pages: 431
  3. Type of Article: Article
  4. Article Number: 431
  5. ISSN: 2235-2988
  1. Abstract:

    Type 2 diabetes mellitus (T2DM) is characterized by heightened systemic inflammation and microbial translocation. Whether concomitant helminth infections can modulate this systemic response is unclear. We examined the presence of markers of systemic inflammation (levels of acute phase proteins) and of microbial translocation [levels of lipopolysaccharide (LPS) and its associated products] in T2DM individuals with (Ss(+)) or without (Ss(-))Strongyloides stercoralis(Ss) infection. We also analyzed these parameters at 6 months following anthelmintic treatment inSs(+)individuals.Ss(+)individuals exhibited significantly diminished levels of alpha-2 macroglobulin, C-reactive protein, haptoglobin and serum amyloid protein A1 compared toSs(-)individuals and these levels increased significantly following therapy. Similarly,Ss(+)individuals exhibited significantly diminished levels of LPS, sCD14, intestinal fatty acid binding protein, LPS binding protein and endotoxin IgG antibody and most of these levels increased significantly following therapy. Thus, helminth infection is associated with attenuation of systemic inflammation and microbial translocation in T2DM and its reversal following anthelmintic therapy.

    See More

External Sources

  1. DOI: 10.3389/fcimb.2020.00431
  2. PMID: 32984066
  3. PMCID: PMC7488178
  4. WOS: 000570550600001

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel